(MENAFN- Straits Research)
Bioabsorbable Stents Market Size & Growth Analysis
The global bioabsorbable stents market size was valued at USD 1.14 billion in 2025 and is projected to grow from USD 1.24 billion in 2026 to USD 2.43 billion by 2034, registering a CAGR of 8.76% during the forecast period from 2026 to 2034. North America dominated the bioabsorbable stents market with a market share of 39.8% in 2025.
Bioabsorbable Stents are medical devices designed to temporarily support blocked or narrowed blood vessels and gradually dissolve or get absorbed by the body over time. They are mainly used in cardiovascular procedures to restore blood flow without leaving a permanent implant. The market is driven by the growing prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and advancements in biodegradable medical technologies.
Bioabsorbable Stents Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 1.14 Billion
2026 Market Size: USD 1.24 Billion
2034 Projected Market Size: USD 2.43 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 8.76%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 39.8%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 10.48%
Segment Insights
By Product
Leading Segment: Coronary Stents
Market Share in 2025: 72.5%
By Material
Fastest-Growing Segment: Polymer-Based Stents
CAGR: 9.18% (2026–2034)
By Absorption Rate
Leading Segment: Slow-absorption Stents
Market Share in 2025: 61.4%
By Application
Fastest-Growing Segment: Coronary Artery Disease
CAGR: 8.94% (2026–2034)
By End-User
Leading Segment: Hospitals
Market Share in 2025: 57.8%
Download a Free Sample To learn more about this report,
Bioabsorbable Stents Market Trends
Growing Focus on Next-Generation Bioresorbable Scaffold Technologies
The bioabsorbable stents market trends are increasingly shaped by efforts to develop safer scaffolds with improved materials, thinner struts, and better implantation performance. Bioabsorbable devices are designed to provide temporary vessel support and, unlike permanent metallic stents, gradually degrade over time. Researchers continue to evaluate whether newer designs can address earlier concerns regarding scaffold thrombosis and long-term clinical outcomes. A major pooled analysis published in JACC: Cardiovascular Interventions in January 2025 examined early and late outcomes from the ABSORB clinical trial program, highlighting continued scientific interest in understanding outcomes before and after complete scaffold bioresorption.
In January 2025, the final ABSORB clinical trial program analysis provided additional long-term evidence on bioresorbable vascular scaffolds compared with metallic everolimus-eluting stents. This continued research is supporting innovation in bioabsorbable stents market trends, particularly around next-generation materials and improved device designs.
Rising Emphasis on Clinical Safety and Regulatory Evaluation
The bioabsorbable stents market is also strongly influenced by regulatory scrutiny and long-term safety evidence. The FDA's PMA database shows that Abbott's Absorb GT1 Bioresorbable Vascular Scaffold was approved in July 2016, but its PMA was subsequently withdrawn in May 2023. Earlier FDA communications had identified higher rates of major adverse cardiac events and device thrombosis compared with a metallic drug-eluting stent in certain follow-up data.
In May 2023, the FDA recorded the withdrawal of the Absorb GT1 BVS System's PMA, underscoring the importance of long-term clinical evidence and post-market monitoring for bioabsorbable coronary devices. This is encouraging developers to place greater emphasis on rigorous clinical trials, optimized implantation techniques, and improved scaffold designs, which will remain important to the future development of the bioabsorbable stents market.
Bioabsorbable Stents Market Dynamics
Market Drivers
Growing Prevalence of Cardiovascular Diseases and Demand for Advanced Interventional Treatments
The bioabsorbable stents market growth is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures to treat narrowed or blocked blood vessels. Bioabsorbable stents are designed to provide temporary vessel support and gradually degrade or become absorbed after completing their intended function, potentially avoiding the long-term presence of a permanent metallic implant. Rising ageing populations, increasing incidence of coronary artery disease, and expanding access to interventional cardiology are supporting market development. The bioabsorbable stents market growth is also fueled by ongoing advancements in biomaterials, drug-eluting technologies, and stent design aimed at improving vascular healing and patient outcomes.
Market Restraints
Clinical Performance Concerns and Complex Regulatory Requirements
The bioabsorbable stents market faces significant restraints due to concerns regarding long-term clinical performance, including risks associated with thrombosis, restenosis, and mechanical durability. Compared with established metallic drug-eluting stents, bioabsorbable technologies require extensive clinical evidence to demonstrate safety and effectiveness across different patient populations. The bioabsorbable stents market analysis also indicates that complex manufacturing processes, high development costs, and stringent regulatory approval requirements can delay commercialization. Limited availability of specialized products and cautious adoption by healthcare providers may further restrict market penetration in certain regions.
Market Opportunities
Advancements in Biomaterials and Next-Generation Stent Technologies
Continuous innovation in biodegradable polymers, bioresorbable metals, and drug-delivery technologies is creating significant opportunities for the bioabsorbable stents market. Manufacturers are developing next-generation devices with improved radial strength, thinner structures, more predictable degradation profiles, and enhanced drug-eluting capabilities. The bioabsorbable stents market analysis highlights opportunities in personalized cardiovascular treatments, improved imaging-guided interventions, and the development of devices designed for specific vascular conditions. Increasing research into magnesium- and polymer-based bioabsorbable materials may further support technological progress. Growing investment in minimally invasive cardiovascular care is expected to create long-term opportunities for market participants.
Market Challenges
Balancing Mechanical Performance, Safety, and Long-Term Clinical Outcomes
One of the major challenges facing the bioabsorbable stents market is achieving sufficient mechanical strength and vessel support while ensuring predictable and safe degradation. Stent performance must remain reliable during the critical healing period without causing adverse effects as the material is absorbed. The bioabsorbable stents market growth is also affected by high research and development costs, complex manufacturing requirements, limited long-term clinical data, and competition from well-established metallic drug-eluting stents. Manufacturers must continue improving device design, clinical evidence, and procedural usability. Balancing innovation, safety, affordability, and long-term clinical performance remains a key challenge for companies operating in the global bioabsorbable stents market.
Bioabsorbable Stents Market Segmentation
By Product
Coronary Stents Dominated the Market with 72.5% Share in 2025
The coronary stents segment accounted for the largest share of the global bioabsorbable stents market at 72.5% in 2025, driven by the high prevalence of coronary artery disease and the growing adoption of advanced minimally invasive cardiovascular procedures.
Peripheral stents continue to support market growth by addressing blockages in peripheral arteries and are increasingly used in the treatment of peripheral vascular conditions.
Request Customization to receive a tailored report.
By Material
Polymer-Based Stents Dominated the Market with 64.7% Share in 2025
The polymer-based stents segment accounted for the largest share of the global bioabsorbable stents market at 64.7% in 2025, supported by their biocompatibility, flexibility, and ability to gradually dissolve after supporting the affected blood vessel.
Metal-based stents continue to play an important role in the market due to their strength and mechanical support, while ongoing technological developments are improving their performance and bioabsorption characteristics.
By Absorption Rate
Slow-Absorption Stents Dominated the Market with 61.4% Share in 2025
The slow-absorption stents segment accounted for the largest share of the global bioabsorbable stents market at 61.4% in 2025, driven by the need for extended structural support during the healing process.
Fast-absorption stents are gaining attention due to their potential to reduce the long-term presence of foreign materials in the body and support faster restoration of natural vessel function.
By Application
Coronary Artery Disease Dominated the Market with 69.2% Share in 2025
The coronary artery disease segment accounted for the largest share of the global bioabsorbable stents market at 69.2% in 2025, supported by the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive treatment options.
Peripheral artery disease also contributes significantly to market demand as bioabsorbable stents are increasingly explored for improving blood flow in affected peripheral vessels. Other applications continue to support the adoption of these advanced cardiovascular treatment solutions.
By End-User
Hospitals Dominated the Market with 57.8% Share in 2025
The hospitals segment accounted for the largest share of the global bioabsorbable stents market at 57.8% in 2025, driven by the availability of advanced cardiac infrastructure, specialized healthcare professionals, and a high volume of cardiovascular procedures.
Cardiac centers continue to play an important role due to their specialized expertise in cardiovascular treatment. Ambulatory surgical centers are gaining traction as healthcare systems increasingly adopt efficient outpatient procedures and minimally invasive treatment approaches.
Speak to an Analyst to discuss market opportunities.
Bioabsorbable Stents Market Regional Outlook
North America Bioabsorbable Stents Market Analysis
North America dominated the bioabsorbable stents market with a 39.8% share, valued at USD 0.45 billion in 2025. The region's leadership is driven by the high prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, strong healthcare infrastructure, and growing investments in advanced medical technologies. Rising demand for innovative coronary intervention solutions and continuous research in bioresorbable materials continue to support regional market growth.
United States Bioabsorbable Stents Market Insights
The United States market accounted for the largest share of the North American market in 2025. Growth is driven by increasing prevalence of coronary artery disease, rising adoption of minimally invasive cardiovascular procedures, growing investments in advanced medical devices, and strong demand for innovative treatment solutions. The presence of major medical technology companies and advanced healthcare infrastructure further strengthens the country's market position.
Unlock Regional Insights to access country-level data, & regional trends.
Asia Pacific Bioabsorbable Stents Market Analysis
Asia Pacific market accounted for 22.6% of the global bioabsorbable stents market, valued at USD 0.26 billion in 2025, and is projected to register the fastest CAGR of 10.48% during the forecast period. The market is expanding due to the growing burden of cardiovascular diseases, increasing healthcare expenditure, improving access to advanced medical treatments, and rising adoption of minimally invasive procedures. Expanding healthcare infrastructure and growing investments in medical technology continue to support regional market growth.
Japan Bioabsorbable Stents Market Insights
Japan market is witnessing steady market growth due to its advanced healthcare system, increasing adoption of innovative cardiovascular technologies, growing demand for minimally invasive procedures, and continuous investments in medical device research and development.
China Bioabsorbable Stents Market Insights
China market accounted for the largest share of the Asia Pacific market in 2025. Growth is supported by the rising prevalence of cardiovascular diseases, increasing healthcare expenditure, expanding hospital infrastructure, growing adoption of advanced medical devices, and rising demand for minimally invasive treatment solutions.
Canada Bioabsorbable Stents Market Insights
Canada market is witnessing steady market growth due to increasing awareness of cardiovascular health, rising adoption of minimally invasive treatment procedures, expanding access to advanced medical technologies, and growing investments in modern healthcare infrastructure.
Europe Bioabsorbable Stents Market Analysis
Europe market accounted for 28.4% of the global bioabsorbable stents market, reaching USD 0.32 billion in 2025. Market growth is supported by increasing demand for advanced cardiovascular treatments, growing adoption of minimally invasive procedures, rising healthcare expenditure, and continuous innovation in bioresorbable medical device technologies. Strong focus on improving cardiovascular care and patient outcomes continues to support regional demand.
United Kingdom Bioabsorbable Stents Market Insights
The United Kingdom market is witnessing steady market growth owing to increasing prevalence of cardiovascular disorders, growing adoption of minimally invasive cardiac procedures, rising investments in advanced healthcare technologies, and increasing demand for innovative stent solutions.
Germany Bioabsorbable Stents Market Insights
Germany market represents one of the largest markets in Europe, driven by its advanced healthcare infrastructure, increasing adoption of innovative cardiovascular devices, growing demand for minimally invasive procedures, and strong investments in medical technology research and development.
Middle East & Africa Bioabsorbable Stents Market Analysis
The Middle East & Africa market represented 4.1% of the global bioabsorbable stents market, totaling USD 0.05 billion in 2025. Rising healthcare investments, increasing prevalence of cardiovascular conditions, expanding access to advanced treatment technologies, and growing demand for minimally invasive procedures are supporting regional market growth.
UAE Bioabsorbable Stents Market Insights
The UAE market is a key market in the Middle East, driven by increasing investments in advanced healthcare infrastructure, growing adoption of innovative cardiovascular technologies, rising medical tourism, and expanding access to specialized cardiac treatment solutions.
Africa Bioabsorbable Stents Market Insights
Africa market is witnessing gradual market growth, supported by increasing investments in healthcare infrastructure, rising awareness of cardiovascular diseases, expanding access to specialized cardiac care, and growing adoption of advanced medical technologies. Countries such as South Africa, Kenya, and Nigeria are creating long-term growth opportunities for market participants.
Competitive Landscape
The global bioabsorbable stents market is moderately competitive, with established medical device companies and specialized cardiovascular technology developers competing across polymer-based and metal-based bioresorbable stents. The key players in the industry are Abbott, Boston Scientific Corporation, Biotronik SE & Co. KG, Elixir Medical Corporation, Medtronic plc, Terumo Corporation, Reva Medical, LLC, Amaranth Medical, Inc., Arterial Remodeling Technologies, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology, Lifetech Scientific Corporation, Meril Life Sciences Pvt. Ltd., ICON Interventional Systems, OrbusNeich Medical, and others. The market is driven by product innovation, clinical evidence, regulatory approvals, and the development of scaffolds with improved radial strength, controlled degradation, and long-term safety.
Industry participants are increasingly focusing on next-generation polymer and magnesium-based bioresorbable technologies to address limitations associated with earlier products. Companies are also investing in clinical trials, advanced imaging integration, strategic partnerships, and expansion into emerging markets to strengthen their competitive position.
Biotronik: A Leading Market Player
Biotronik is a prominent player in the bioabsorbable stents market, with a strong focus on magnesium-based bioresorbable scaffold technology. The company has differentiated itself through the development of the DREAMS platform, designed to provide vessel support while gradually being absorbed by the body. Its technology focus on metal-like handling and predictable resorption supports its competitive position in the market.
Biotronik's next-generation bioresorbable scaffold platform has received significant regulatory attention, including FDA Breakthrough Device Designation for its Freesolve coronary scaffold technology, highlighting continued innovation in magnesium-based bioresorbable stent development.
List of Key and Emerging Players in Bioabsorbable Stents Market
Abbott
Boston Scientific Corporation
Biotronik SE & Co. KG
Elixir Medical Corporation
Medtronic plc
Terumo Corporation
Reva Medical, LLC
Amaranth Medical, Inc.
Arterial Remodeling Technologies
Kyoto Medical Planning Co., Ltd.
Lepu Medical Technology
Lifetech Scientific Corporation
Meril Life Sciences Pvt. Ltd.
ICON Interventional Systems
OrbusNeich Medical
Key Industry Developments
April 2026: Biotronik expanded its bioresorbable vascular technology portfolio through next-generation scaffold development focused on improving long-term vessel healing and reducing restenosis risk.
February 2026: Reva Medical advanced development of its bioresorbable scaffold platform through expanded clinical evaluation programs designed to assess safety and long-term efficacy in coronary artery disease treatment.
October 2025: Elixir Medical expanded its cardiovascular product portfolio by advancing clinical development of its DynamX® bioadaptor system, designed to restore natural vessel motion after implantation.
June 2025: Amaranth Medical strengthened its bioresorbable scaffold development program through continued technology enhancements aimed at improving scaffold strength and controlled bioabsorption.
Report Scope
Comments
No comment